Sulfonamide compounds useful as CYP17 inhibitors

Disclosed are sulfonamide compounds of Formula (I): or stereoisomers, N-oxides, prodrugs, or pharmaceutically acceptable salts thereof, wherein ring A, R1, R2, R3, R4 and R5 are defined herein. Also disclosed are methods of using such compounds in the treatment of conditions related to CYP17 enzyme,...

Full description

Saved in:
Bibliographic Details
Main Authors SHARMA LISA S, DARNE CHETAN PADMAKAR, AUSTIN JOEL FRANCIS, BALOG JAMES AARON, HUANG AUDRIS, SAULNIER MARK GEORGE, VELAPARTHI UPENDER
Format Patent
LanguageEnglish
Published 23.12.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Disclosed are sulfonamide compounds of Formula (I): or stereoisomers, N-oxides, prodrugs, or pharmaceutically acceptable salts thereof, wherein ring A, R1, R2, R3, R4 and R5 are defined herein. Also disclosed are methods of using such compounds in the treatment of conditions related to CYP17 enzyme, such as cancer, and pharmaceutical compositions comprising such compounds.
Bibliography:Application Number: US201113812056